FATE THERAPEUTICS, INC. (FATE) Operating cash flow 2016–2025
FATE THERAPEUTICS, INC. (FATE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$106.1MFY2025 · since FY2016: -$29.8M → -$106.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$106.1M | +13.7% |
| FY2024 | -$122.9M | +7.1% |
| FY2023 | -$132.3M | +46.7% |
| FY2022 | -$248.2M | -52.4% |
| FY2021 | -$162.9M | -315.2% |
| FY2020 | -$39.2M | +52.8% |
| FY2019 | -$83.2M | -115.2% |
| FY2018 | -$38.6M | -5.0% |
| FY2017 | -$36.8M | -23.5% |
| FY2016 | -$29.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice